Variant mutation G215C in SARS-CoV-2 nucleocapsid enhances viral infection via altered genomic encapsidation.

The evolution of SARS-CoV-2 variants and their respective phenotypes represents an important set of tools to understand basic coronavirus biology as well as the public health implications of individual mutations in variants of concern. While mutations outside of spike are not well studied, the entir...

Full description

Saved in:
Bibliographic Details
Main Authors: Hannah C Kubinski, Hannah W Despres, Bryan A Johnson, Madaline M Schmidt, Sara A Jaffrani, Allyson H Turner, Conor D Fanuele, Margaret G Mills, Kumari G Lokugamage, Caroline M Dumas, David J Shirley, Leah K Estes, Andrew Pekosz, Jessica W Crothers, Pavitra Roychoudhury, Alexander L Greninger, Keith R Jerome, Bruno Martorelli Di Genova, David H Walker, Bryan A Ballif, Mark S Ladinsky, Pamela J Bjorkman, Vineet D Menachery, Emily A Bruce
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2025-04-01
Series:PLoS Biology
Online Access:https://doi.org/10.1371/journal.pbio.3003115
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850144456918958080
author Hannah C Kubinski
Hannah W Despres
Bryan A Johnson
Madaline M Schmidt
Sara A Jaffrani
Allyson H Turner
Conor D Fanuele
Margaret G Mills
Kumari G Lokugamage
Caroline M Dumas
David J Shirley
Leah K Estes
Andrew Pekosz
Jessica W Crothers
Pavitra Roychoudhury
Alexander L Greninger
Keith R Jerome
Bruno Martorelli Di Genova
David H Walker
Bryan A Ballif
Mark S Ladinsky
Pamela J Bjorkman
Vineet D Menachery
Emily A Bruce
author_facet Hannah C Kubinski
Hannah W Despres
Bryan A Johnson
Madaline M Schmidt
Sara A Jaffrani
Allyson H Turner
Conor D Fanuele
Margaret G Mills
Kumari G Lokugamage
Caroline M Dumas
David J Shirley
Leah K Estes
Andrew Pekosz
Jessica W Crothers
Pavitra Roychoudhury
Alexander L Greninger
Keith R Jerome
Bruno Martorelli Di Genova
David H Walker
Bryan A Ballif
Mark S Ladinsky
Pamela J Bjorkman
Vineet D Menachery
Emily A Bruce
author_sort Hannah C Kubinski
collection DOAJ
description The evolution of SARS-CoV-2 variants and their respective phenotypes represents an important set of tools to understand basic coronavirus biology as well as the public health implications of individual mutations in variants of concern. While mutations outside of spike are not well studied, the entire viral genome is undergoing evolutionary selection, with several variants containing mutations in the central disordered linker region of the nucleocapsid (N) protein. Here, we identify a mutation (G215C), characteristic of the Delta variant, that introduces a novel cysteine into this linker domain, which results in the formation of a more stable N-N dimer. Using reverse genetics, we determined that this cysteine residue is necessary and sufficient for stable dimer formation in a WA1 SARS-CoV-2 background, where it results in significantly increased viral growth both in vitro and in vivo. Mechanistically, we show that the N:G215C mutant has more encapsidation as measured by increased RNA binding to N, N incorporation into virions, and electron microscopy showing that individual virions are larger, with elongated morphologies.
format Article
id doaj-art-e1058cfde9b149899144790e960f36db
institution OA Journals
issn 1544-9173
1545-7885
language English
publishDate 2025-04-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Biology
spelling doaj-art-e1058cfde9b149899144790e960f36db2025-08-20T02:28:22ZengPublic Library of Science (PLoS)PLoS Biology1544-91731545-78852025-04-01234e300311510.1371/journal.pbio.3003115Variant mutation G215C in SARS-CoV-2 nucleocapsid enhances viral infection via altered genomic encapsidation.Hannah C KubinskiHannah W DespresBryan A JohnsonMadaline M SchmidtSara A JaffraniAllyson H TurnerConor D FanueleMargaret G MillsKumari G LokugamageCaroline M DumasDavid J ShirleyLeah K EstesAndrew PekoszJessica W CrothersPavitra RoychoudhuryAlexander L GreningerKeith R JeromeBruno Martorelli Di GenovaDavid H WalkerBryan A BallifMark S LadinskyPamela J BjorkmanVineet D MenacheryEmily A BruceThe evolution of SARS-CoV-2 variants and their respective phenotypes represents an important set of tools to understand basic coronavirus biology as well as the public health implications of individual mutations in variants of concern. While mutations outside of spike are not well studied, the entire viral genome is undergoing evolutionary selection, with several variants containing mutations in the central disordered linker region of the nucleocapsid (N) protein. Here, we identify a mutation (G215C), characteristic of the Delta variant, that introduces a novel cysteine into this linker domain, which results in the formation of a more stable N-N dimer. Using reverse genetics, we determined that this cysteine residue is necessary and sufficient for stable dimer formation in a WA1 SARS-CoV-2 background, where it results in significantly increased viral growth both in vitro and in vivo. Mechanistically, we show that the N:G215C mutant has more encapsidation as measured by increased RNA binding to N, N incorporation into virions, and electron microscopy showing that individual virions are larger, with elongated morphologies.https://doi.org/10.1371/journal.pbio.3003115
spellingShingle Hannah C Kubinski
Hannah W Despres
Bryan A Johnson
Madaline M Schmidt
Sara A Jaffrani
Allyson H Turner
Conor D Fanuele
Margaret G Mills
Kumari G Lokugamage
Caroline M Dumas
David J Shirley
Leah K Estes
Andrew Pekosz
Jessica W Crothers
Pavitra Roychoudhury
Alexander L Greninger
Keith R Jerome
Bruno Martorelli Di Genova
David H Walker
Bryan A Ballif
Mark S Ladinsky
Pamela J Bjorkman
Vineet D Menachery
Emily A Bruce
Variant mutation G215C in SARS-CoV-2 nucleocapsid enhances viral infection via altered genomic encapsidation.
PLoS Biology
title Variant mutation G215C in SARS-CoV-2 nucleocapsid enhances viral infection via altered genomic encapsidation.
title_full Variant mutation G215C in SARS-CoV-2 nucleocapsid enhances viral infection via altered genomic encapsidation.
title_fullStr Variant mutation G215C in SARS-CoV-2 nucleocapsid enhances viral infection via altered genomic encapsidation.
title_full_unstemmed Variant mutation G215C in SARS-CoV-2 nucleocapsid enhances viral infection via altered genomic encapsidation.
title_short Variant mutation G215C in SARS-CoV-2 nucleocapsid enhances viral infection via altered genomic encapsidation.
title_sort variant mutation g215c in sars cov 2 nucleocapsid enhances viral infection via altered genomic encapsidation
url https://doi.org/10.1371/journal.pbio.3003115
work_keys_str_mv AT hannahckubinski variantmutationg215cinsarscov2nucleocapsidenhancesviralinfectionviaalteredgenomicencapsidation
AT hannahwdespres variantmutationg215cinsarscov2nucleocapsidenhancesviralinfectionviaalteredgenomicencapsidation
AT bryanajohnson variantmutationg215cinsarscov2nucleocapsidenhancesviralinfectionviaalteredgenomicencapsidation
AT madalinemschmidt variantmutationg215cinsarscov2nucleocapsidenhancesviralinfectionviaalteredgenomicencapsidation
AT saraajaffrani variantmutationg215cinsarscov2nucleocapsidenhancesviralinfectionviaalteredgenomicencapsidation
AT allysonhturner variantmutationg215cinsarscov2nucleocapsidenhancesviralinfectionviaalteredgenomicencapsidation
AT conordfanuele variantmutationg215cinsarscov2nucleocapsidenhancesviralinfectionviaalteredgenomicencapsidation
AT margaretgmills variantmutationg215cinsarscov2nucleocapsidenhancesviralinfectionviaalteredgenomicencapsidation
AT kumariglokugamage variantmutationg215cinsarscov2nucleocapsidenhancesviralinfectionviaalteredgenomicencapsidation
AT carolinemdumas variantmutationg215cinsarscov2nucleocapsidenhancesviralinfectionviaalteredgenomicencapsidation
AT davidjshirley variantmutationg215cinsarscov2nucleocapsidenhancesviralinfectionviaalteredgenomicencapsidation
AT leahkestes variantmutationg215cinsarscov2nucleocapsidenhancesviralinfectionviaalteredgenomicencapsidation
AT andrewpekosz variantmutationg215cinsarscov2nucleocapsidenhancesviralinfectionviaalteredgenomicencapsidation
AT jessicawcrothers variantmutationg215cinsarscov2nucleocapsidenhancesviralinfectionviaalteredgenomicencapsidation
AT pavitraroychoudhury variantmutationg215cinsarscov2nucleocapsidenhancesviralinfectionviaalteredgenomicencapsidation
AT alexanderlgreninger variantmutationg215cinsarscov2nucleocapsidenhancesviralinfectionviaalteredgenomicencapsidation
AT keithrjerome variantmutationg215cinsarscov2nucleocapsidenhancesviralinfectionviaalteredgenomicencapsidation
AT brunomartorellidigenova variantmutationg215cinsarscov2nucleocapsidenhancesviralinfectionviaalteredgenomicencapsidation
AT davidhwalker variantmutationg215cinsarscov2nucleocapsidenhancesviralinfectionviaalteredgenomicencapsidation
AT bryanaballif variantmutationg215cinsarscov2nucleocapsidenhancesviralinfectionviaalteredgenomicencapsidation
AT marksladinsky variantmutationg215cinsarscov2nucleocapsidenhancesviralinfectionviaalteredgenomicencapsidation
AT pamelajbjorkman variantmutationg215cinsarscov2nucleocapsidenhancesviralinfectionviaalteredgenomicencapsidation
AT vineetdmenachery variantmutationg215cinsarscov2nucleocapsidenhancesviralinfectionviaalteredgenomicencapsidation
AT emilyabruce variantmutationg215cinsarscov2nucleocapsidenhancesviralinfectionviaalteredgenomicencapsidation